Literature DB >> 9169803

Prognostic factors in adult soft-tissue sarcomas of the head and neck.

Q T Le1, K K Fu, S Kroll, L Fitts, V Massullo, L Ferrell, M J Kaplan, T L Phillips.   

Abstract

PURPOSE: The main objectives of this study were (a) to review the treatment results of primary head and neck soft-tissue sarcoma at our institution, (b) to identify important prognostic factors in local control and survival, and (c) to assess the efficacy of salvage therapy. METHODS AND MATERIALS: Sixty-five patients were treated at the University of California, San Francisco, between 1961 and 1993. Seventeen patients (27%) had low-grade, 10 (15%) had intermediate-grade, and 38 (58%) had high-grade sarcomas. Tumors were > 5 cm in 35 patients. Local management consisted of surgery alone in 14 patients (22%), surgery and radiotherapy in 40 (61%), and radiotherapy alone in 11 (17%) patients. The median follow-up was 64 months.
RESULTS: The 5-year actuarial local control rate of the entire group was 66%. Tumor size and grade were important predictors for local control on multivariate analysis. The actuarial local control rate at 5 years was 92% for T1 vs. 40% for T2 primaries (p = 0.004), and 80% for Grade 1-2 vs. 48% for Grade 3 tumors (p = 0.01). None of the patients treated with radiotherapy alone with a dose of 50-65 Gy were controlled locally. Combined radiotherapy and surgery appeared to yield superior local control compared to surgery alone (77% vs. 59%); however, the difference was not statistically significant. The 5-year actuarial overall and cause-specific survivals were 56% and 60%, respectively. Unfavorable prognostic factors for cause-specific survival on multivariate analysis were age > 55 (p = 0.009), high tumor grade (p = 0.0002), inadequate surgery (p = 0.008), and positive surgical margins (p = 0.0009). In patients who underwent salvage therapy for treatment failure, the 5-year actuarial survival after salvage treatment was 26%.
CONCLUSION: Tumor size and grade were important predictors for local control. Age, grade, adequacy of surgery, and status of surgical margins were significant prognostic factors for survival. There was a trend of improved local control with combined surgery and radiotherapy compared to either modality alone for high-risk patients. Radiotherapy alone with doses < or = 65 Gy was insufficient for control of gross disease. Aggressive salvage therapy was worthwhile in patients whose disease was uncontrolled after the initial treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9169803     DOI: 10.1016/s0360-3016(97)00103-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Maxillary Sinus Sarcomas: Epidemiological and Clinicopathological Experience of 25 Years in a National Reference Cancer Center.

Authors:  Rosa Angélica Salcedo-Hernández; Leonardo Saúl Lino-Silva; Kuauhyama Luna-Ortiz
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-22

Review 2.  Sarcomas of the head and neck.

Authors:  Dennis H Kraus
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

3.  Head and neck sarcomas: analysis of the SEER database.

Authors:  Kevin A Peng; Tristan Grogan; Marilene B Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2014-08-18       Impact factor: 3.497

4.  Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy.

Authors:  Pierre Heudel; Marie Claude Biston; Jérome Fayette; Antoine Ramade; Frédéric Gassa; Pascal Pommier
Journal:  Int J Clin Oncol       Date:  2010-03-02       Impact factor: 3.402

5.  Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.

Authors:  Franziska Eckert; Christiane Matuschek; Arndt-Christian Mueller; Martin Weinmann; Joerg T Hartmann; Claus Belka; Wilfried Budach
Journal:  Radiat Oncol       Date:  2010-06-16       Impact factor: 3.481

6.  Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma.

Authors:  Seung Cheol Ha; Jungsu S Oh; Jong-Lyel Roh; Hyojeong Moon; Jae Seung Kim; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-23       Impact factor: 9.236

7.  Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series.

Authors:  Brian O'Sullivan; Patrick Gullane; Jonathan Irish; Peter Neligan; Fred Gentili; James Mahoney; Susanna Sellmann; Charles Catton; John Waldron; Dale Brown; Ian Witterick; Jeremy Freeman; Robert Bell
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

8.  [Soft tissue tumors of the head and neck region].

Authors:  W Laffers; G Stöhr; F Göke; E Wardelmann; S Keiner; M Zipfel; H Schüller; A O H Gerstner
Journal:  HNO       Date:  2013-11       Impact factor: 1.284

9.  Sarcomas of head and neck - A 10 yrs experience.

Authors:  Abhishek Srivastava; Anirban Ghosh; Somnath Saha; V P Saha; Debdulal Chakraborty
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-12-11

Review 10.  Advances in neoadjuvant chemotherapy in soft tissue sarcomas.

Authors:  Alexandria Phan; Shreyaskumar Patel
Journal:  Curr Treat Options Oncol       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.